Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation

Documenti analoghi

• Traumatic Brain Injury‐associated gene network‐based prediction and population‐based validation identifies doxycycline as a repurposable medicine for Alzheimer’s Disease
  di: Marina Bykova, et al.
  Pubblicazione: (2025)
• Alzheimer's disease drug development pipeline: 2026
  di: Jeffrey L. Cummings, et al.
  Pubblicazione: (2026)
• Alzheimer's disease drug development pipeline: 2025
  di: Jeffrey L. Cummings, et al.
  Pubblicazione: (2025)
• Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
  di: Xiaojuan Li, et al.
  Pubblicazione: (2025)
• Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease
  di: Yi Shi, et al.
  Pubblicazione: (2026)